Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1 inhibition

Gelijkaardige items

• Hypoxia promotes BCMA loss and a suppressive secretome thereby hindering CAR T cell therapy in multiple myeloma
  door: Chenggong Tu, et al.
  Gepubliceerd in: (2026-01-01)
• Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1 inhibition
  door: Mérédis Favreau, et al.
  Gepubliceerd in: (2017-07-01)
• PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism
  door: Inge Oudaert, et al.
  Gepubliceerd in: (2026-02-01)
• Fueling CARs: metabolic strategies to enhance CAR T-cell therapy
  door: Arne Van der Vreken, et al.
  Gepubliceerd in: (2024-07-01)
• Targeting mTOR signaling pathways in multiple myeloma: biology and implication for therapy
  door: Yanmeng Wang, et al.
  Gepubliceerd in: (2024-06-01)